Current Drug Therapy

Marzieh Salehi, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

David A. D’Alessio, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

Address: Marzieh Salehi, MD, Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, PO Box 670547, Cincinnati, OH 45267-0547; e-mail salehim@email.uc.edu

Marzieh Salehi, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

David A. D’Alessio, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

Address: Marzieh Salehi, MD, Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, PO Box 670547, Cincinnati, OH 45267-0547; e-mail salehim@email.uc.edu

Marzieh Salehi, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

David A. D’Alessio, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

Address: Marzieh Salehi, MD, Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, PO Box 670547, Cincinnati, OH 45267-0547; e-mail salehim@email.uc.edu

Elias A. Khawam, MD
Louis Stokes Cleveland VA Medical Center; Senior Instructor, Department of Psychiatry, Case Western Reserve University

Georgia Laurencic, MD
Department of Psychiatry and Psychology, Cleveland Clinic

Donald A. Malone Jr., MD
Head, Section of Adult Primary Services, Department of Psychiatry and Psychology, Cleveland Clinic

Address: Donald Malone, Jr., MD, Department of Psychiatry and Psychology, P57, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail maloned@ccf.org

Elias A. Khawam, MD
Louis Stokes Cleveland VA Medical Center; Senior Instructor, Department of Psychiatry, Case Western Reserve University

Georgia Laurencic, MD
Department of Psychiatry and Psychology, Cleveland Clinic

Donald A. Malone Jr., MD
Head, Section of Adult Primary Services, Department of Psychiatry and Psychology, Cleveland Clinic

Address: Donald Malone, Jr., MD, Department of Psychiatry and Psychology, P57, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail maloned@ccf.org

Elias A. Khawam, MD
Louis Stokes Cleveland VA Medical Center; Senior Instructor, Department of Psychiatry, Case Western Reserve University

Georgia Laurencic, MD
Department of Psychiatry and Psychology, Cleveland Clinic

Donald A. Malone Jr., MD
Head, Section of Adult Primary Services, Department of Psychiatry and Psychology, Cleveland Clinic

Address: Donald Malone, Jr., MD, Department of Psychiatry and Psychology, P57, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail maloned@ccf.org

Bertram Pitt, MD
University of Michigan School of Medicine, Ann Arbor, MI; investigator in the RALES, EPHESUS, and 4E trials

Sanjay Rajagopalan, MD
Mt. Sinai School of Medicine, New York, NY

Address: Sanjay Rajagopalan, MD, One Gustave Levy Place, Box 1030, New York, NY 10029; e-mail sanjay.Rajagopalan@mssm.edu

Dr. Pitt has indicated that he serves as a consultant for the Pfizer corporation.

Bertram Pitt, MD
University of Michigan School of Medicine, Ann Arbor, MI; investigator in the RALES, EPHESUS, and 4E trials

Sanjay Rajagopalan, MD
Mt. Sinai School of Medicine, New York, NY

Address: Sanjay Rajagopalan, MD, One Gustave Levy Place, Box 1030, New York, NY 10029; e-mail sanjay.Rajagopalan@mssm.edu

Dr. Pitt has indicated that he serves as a consultant for the Pfizer corporation.

Bertram Pitt, MD
University of Michigan School of Medicine, Ann Arbor, MI; investigator in the RALES, EPHESUS, and 4E trials

Sanjay Rajagopalan, MD
Mt. Sinai School of Medicine, New York, NY

Address: Sanjay Rajagopalan, MD, One Gustave Levy Place, Box 1030, New York, NY 10029; e-mail sanjay.Rajagopalan@mssm.edu

Dr. Pitt has indicated that he serves as a consultant for the Pfizer corporation.

John J. Carey, MD
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: John J. Carey, MD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail careyj@ccf.org

Dr. Carey has indicated that he has received grant or research support from the Proctor and Gamble corporation, serves as a consultant for Eli Lilly and Company, and is on the speaker’s bureau of Proctor and Gamble.

John J. Carey, MD
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: John J. Carey, MD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail careyj@ccf.org

Dr. Carey has indicated that he has received grant or research support from the Proctor and Gamble corporation, serves as a consultant for Eli Lilly and Company, and is on the speaker’s bureau of Proctor and Gamble.

John J. Carey, MD
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: John J. Carey, MD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail careyj@ccf.org

Dr. Carey has indicated that he has received grant or research support from the Proctor and Gamble corporation, serves as a consultant for Eli Lilly and Company, and is on the speaker’s bureau of Proctor and Gamble.

Abu R. Vasudevan, MBBS, MD, MRCP
Clinical Instructor, Division of Endocrinology and Metabolism, Center for Cardiovascular Disease Prevention, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Yasmin S. Hamirani, MBBS
Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Peter H. Jones, MD
Associate Professor, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Suite B160, Mail stop A601, Houston, TX 77030; e-mail jones@bcm.tmc.edu

Dr. Jones has indicated that he has received grant or research support from the Abbott, AstraZeneca, KOS, and Pfizer corporations.

Abu R. Vasudevan, MBBS, MD, MRCP
Clinical Instructor, Division of Endocrinology and Metabolism, Center for Cardiovascular Disease Prevention, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Yasmin S. Hamirani, MBBS
Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Peter H. Jones, MD
Associate Professor, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Suite B160, Mail stop A601, Houston, TX 77030; e-mail jones@bcm.tmc.edu

Dr. Jones has indicated that he has received grant or research support from the Abbott, AstraZeneca, KOS, and Pfizer corporations.

Abu R. Vasudevan, MBBS, MD, MRCP
Clinical Instructor, Division of Endocrinology and Metabolism, Center for Cardiovascular Disease Prevention, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Yasmin S. Hamirani, MBBS
Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Peter H. Jones, MD
Associate Professor, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, Lipid and Atherosclerosis Section, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Suite B160, Mail stop A601, Houston, TX 77030; e-mail jones@bcm.tmc.edu

Dr. Jones has indicated that he has received grant or research support from the Abbott, AstraZeneca, KOS, and Pfizer corporations.

Ewa Olech, MD
Clinical Pharmacology Research Program,Oklahoma Medical Research Foundation; Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City

Joan T. Merrill, MD
Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and Professor of Medicine, Oklahoma Health Sciences Center, Oklahoma City; Medical Director, Lupus Foundation of America

Address: Joan T. Merrill, MD, Oklahoma Medical Research Foundation, 825 Northeast 13th Street, Oklahoma City, OK 73104

Dr. Merrill has indicated that she is a consultant for Genelabs and has received grant or research support from Genelabs.

Ewa Olech, MD
Clinical Pharmacology Research Program,Oklahoma Medical Research Foundation; Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City

Joan T. Merrill, MD
Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and Professor of Medicine, Oklahoma Health Sciences Center, Oklahoma City; Medical Director, Lupus Foundation of America

Address: Joan T. Merrill, MD, Oklahoma Medical Research Foundation, 825 Northeast 13th Street, Oklahoma City, OK 73104

Dr. Merrill has indicated that she is a consultant for Genelabs and has received grant or research support from Genelabs.

Ewa Olech, MD
Clinical Pharmacology Research Program,Oklahoma Medical Research Foundation; Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City

Joan T. Merrill, MD
Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and Professor of Medicine, Oklahoma Health Sciences Center, Oklahoma City; Medical Director, Lupus Foundation of America

Address: Joan T. Merrill, MD, Oklahoma Medical Research Foundation, 825 Northeast 13th Street, Oklahoma City, OK 73104

Dr. Merrill has indicated that she is a consultant for Genelabs and has received grant or research support from Genelabs.

Russell L. Silverstein, MD
Senior Physician and Vice President, Dallas Nephrology Associates, Dallas, TX

C. Venkata S. Ram, MD
Director, Texas Blood Pressure Institute, Dallas Nephrology Associates; University of Texas Southwestern Medical School, Dallas, TX

Address: C. Venkata S. Ram, MD, Director, Texas Blood Pressure Institute, 1420 Viceroy Drive, Dallas, TX 75235; e-mail ramv@dneph.com

Russell L. Silverstein, MD
Senior Physician and Vice President, Dallas Nephrology Associates, Dallas, TX

C. Venkata S. Ram, MD
Director, Texas Blood Pressure Institute, Dallas Nephrology Associates; University of Texas Southwestern Medical School, Dallas, TX

Address: C. Venkata S. Ram, MD, Director, Texas Blood Pressure Institute, 1420 Viceroy Drive, Dallas, TX 75235; e-mail ramv@dneph.com

Russell L. Silverstein, MD
Senior Physician and Vice President, Dallas Nephrology Associates, Dallas, TX

C. Venkata S. Ram, MD
Director, Texas Blood Pressure Institute, Dallas Nephrology Associates; University of Texas Southwestern Medical School, Dallas, TX

Address: C. Venkata S. Ram, MD, Director, Texas Blood Pressure Institute, 1420 Viceroy Drive, Dallas, TX 75235; e-mail ramv@dneph.com

Peter H. Jones, MD
Associate Professor of Medicine; Director of Clinical Trials; Co-director, Lipid Metabolism and Atherosclerosis Clinic; Section of Atherosclerosis and Lipid Research, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, FACP, 6565 Fannin Street, A601, Houston, TX 77030; e-mail jones@bcm.tmc.edu

The author has indicated that he has received research grants from the Pfizer, AstraZeneca, Kos, and Abbott corporations.

Peter H. Jones, MD
Associate Professor of Medicine; Director of Clinical Trials; Co-director, Lipid Metabolism and Atherosclerosis Clinic; Section of Atherosclerosis and Lipid Research, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, FACP, 6565 Fannin Street, A601, Houston, TX 77030; e-mail jones@bcm.tmc.edu

The author has indicated that he has received research grants from the Pfizer, AstraZeneca, Kos, and Abbott corporations.

Peter H. Jones, MD
Associate Professor of Medicine; Director of Clinical Trials; Co-director, Lipid Metabolism and Atherosclerosis Clinic; Section of Atherosclerosis and Lipid Research, Baylor College of Medicine, Houston, TX

Address: Peter H. Jones, MD, FACP, 6565 Fannin Street, A601, Houston, TX 77030; e-mail jones@bcm.tmc.edu

The author has indicated that he has received research grants from the Pfizer, AstraZeneca, Kos, and Abbott corporations.

Nasser Mikhail, MD, MSc
Chief, Endocrinology Division, Department of Medicine, Olive View-UCLA Medical Center, Sylmar, CA

Address: Nasser Mikhail, MD, MSc, Chief, Endocrinology Division, Department of Medicine, Olive View-UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342-1495; e-mail nmikhail@ladhs.org

Nasser Mikhail, MD, MSc
Chief, Endocrinology Division, Department of Medicine, Olive View-UCLA Medical Center, Sylmar, CA

Address: Nasser Mikhail, MD, MSc, Chief, Endocrinology Division, Department of Medicine, Olive View-UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342-1495; e-mail nmikhail@ladhs.org

Nasser Mikhail, MD, MSc
Chief, Endocrinology Division, Department of Medicine, Olive View-UCLA Medical Center, Sylmar, CA

Address: Nasser Mikhail, MD, MSc, Chief, Endocrinology Division, Department of Medicine, Olive View-UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342-1495; e-mail nmikhail@ladhs.org

Chad Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

James Gideon, MD, PhD
Blanchard Valley Medical Associates, Findlay, OH

Address: Chad Deal, MD, Department of Rheumatic and Immunologic Disease, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Deal has indicated that he serves as a consultant for and is on the speaker’s bureau of Eli Lilly and Company.

Chad Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

James Gideon, MD, PhD
Blanchard Valley Medical Associates, Findlay, OH

Address: Chad Deal, MD, Department of Rheumatic and Immunologic Disease, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Deal has indicated that he serves as a consultant for and is on the speaker’s bureau of Eli Lilly and Company.

Chad Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

James Gideon, MD, PhD
Blanchard Valley Medical Associates, Findlay, OH

Address: Chad Deal, MD, Department of Rheumatic and Immunologic Disease, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Deal has indicated that he serves as a consultant for and is on the speaker’s bureau of Eli Lilly and Company.